Operating Expenses Summary of Beximco Pharmaceuticals Limited

Beximco Pharmaceuticals Limited's latest annual operating expenses in 2023 was 10.95 Billion BDT , N/A from previous year.
Beximco Pharmaceuticals Limited's latest quarterly operating expenses in 2023 Q3 was 2.91 Billion BDT , up 5.74% from previous quarter.
Beximco Pharmaceuticals Limited reported a annual operating expenses of 9.89 Billion BDT in annual operating expenses 2022, up 12.29% from previous year.
Beximco Pharmaceuticals Limited reported a annual operating expenses of 9.27 Billion BDT in annual operating expenses 2021, up 22.07% from previous year.
Beximco Pharmaceuticals Limited reported a quarterly operating expenses of 2.53 Billion BDT for 2023 Q1, down -6.16% from previous quarter.
Beximco Pharmaceuticals Limited reported a quarterly operating expenses of 2.75 Billion BDT for 2023 Q2, up 8.78% from previous quarter.

Annual Operating Expenses Chart of Beximco Pharmaceuticals Limited (2023 - 2005)

Historical Annual Operating Expenses of Beximco Pharmaceuticals Limited (2023 - 2005)

Year	Operating Expenses	Operating Expenses Growth
2023	10.95 Billion BDT	N/A
2022	9.89 Billion BDT	12.29%
2021	9.27 Billion BDT	22.07%
2020	7.59 Billion BDT	16.4%
2019	6.52 Billion BDT	13.38%
2018	5.75 Billion BDT	29.97%
2017	4.42 Billion BDT	14.09%
2016	3.88 Billion BDT	18.84%
2015	3.26 Billion BDT	17.0%
2014	2.79 Billion BDT	6.58%
2013	2.61 Billion BDT	15.03%
2012	2.27 Billion BDT	26.13%
2011	1.8 Billion BDT	16.73%
2010	1.54 Billion BDT	5.39%
2009	1.46 Billion BDT	45.53%
2008	1 Billion BDT	2.98%
2007	979.16 Million BDT	-1.6%
2006	995.03 Million BDT	19.15%
2005	835.13 Million BDT	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 Q3	2.91 Billion BDT	5.74%
2023 Q1	2.53 Billion BDT	-6.16%
2023 Q2	2.75 Billion BDT	8.78%
2022 Q1	2.41 Billion BDT	-11.84%
2022 FY	10.41 Billion BDT	12.29%
2022 Q4	2.69 Billion BDT	-1.87%
2022 Q3	2.75 Billion BDT	7.81%
2022 Q2	2.55 Billion BDT	5.81%
2021 Q4	2.73 Billion BDT	16.47%
2021 Q3	2.34 Billion BDT	-1.3%
2021 Q2	2.37 Billion BDT	18.72%
2021 FY	9.27 Billion BDT	22.07%
2021 Q1	2 Billion BDT	-20.36%
2020 Q2	1.82 Billion BDT	12.69%
2020 Q3	1.8 Billion BDT	-0.82%
2020 Q4	2.51 Billion BDT	39.13%
2020 Q1	1.61 Billion BDT	-8.28%
2020 FY	7.59 Billion BDT	16.4%
2019 FY	6.52 Billion BDT	13.38%
2019 Q4	1.76 Billion BDT	4.92%
2019 Q3	1.68 Billion BDT	5.14%
2019 Q2	1.59 Billion BDT	2.17%
2019 Q1	1.56 Billion BDT	10.89%
2018 Q4	1.41 Billion BDT	-7.82%
2018 FY	5.75 Billion BDT	29.97%
2018 Q2	1.43 Billion BDT	6.29%
2018 Q1	1.34 Billion BDT	10.37%
2018 Q3	1.53 Billion BDT	6.8%
2017 Q3	1.11 Billion BDT	8.38%
2017 FY	4.42 Billion BDT	14.09%
2017 Q4	1.22 Billion BDT	10.02%
2017 Q2	1.02 Billion BDT	-3.07%
2017 Q1	1.05 Billion BDT	3.77%
2016 Q2	955.11 Million BDT	5.72%
2016 Q1	903.44 Million BDT	6.29%
2016 Q4	1.01 Billion BDT	1.53%
2016 FY	3.88 Billion BDT	18.84%
2016 Q3	1 Billion BDT	5.08%
2015 Q4	849.98 Million BDT	2.22%
2015 Q1	824.12 Million BDT	2.57%
2015 FY	3.26 Billion BDT	17.0%
2015 Q2	905.88 Million BDT	9.92%
2015 Q3	831.56 Million BDT	-8.2%
2014 Q1	733.43 Million BDT	8.19%
2014 Q4	803.45 Million BDT	9.69%
2014 FY	2.79 Billion BDT	6.58%
2014 Q2	722.87 Million BDT	-1.44%
2014 Q3	732.45 Million BDT	1.32%
2013 Q2	740.74 Million BDT	15.53%
2013 FY	2.61 Billion BDT	15.03%
2013 Q4	677.93 Million BDT	3.15%
2013 Q1	641.18 Million BDT	-1.1%
2013 Q3	657.25 Million BDT	-11.27%
2012 Q4	648.3 Million BDT	10.07%
2012 Q2	748.4 Million BDT	33.1%
2012 Q1	562.3 Million BDT	13.83%
2012 FY	2.27 Billion BDT	26.13%
2012 Q3	588.97 Million BDT	-21.3%
2011 Q3	514.72 Million BDT	-4.87%
2011 Q4	493.96 Million BDT	-4.03%
2011 Q2	541.04 Million BDT	17.34%
2011 FY	1.8 Billion BDT	16.73%
2011 Q1	461.08 Million BDT	10.05%
2010 Q3	384.16 Million BDT	-11.07%
2010 Q1	411.98 Million BDT	1.82%
2010 FY	1.54 Billion BDT	5.39%
2010 Q4	418.96 Million BDT	9.06%
2010 Q2	431.99 Million BDT	4.86%
2009 Q4	404.61 Million BDT	35.79%
2009 Q3	297.95 Million BDT	-47.15%
2009 FY	1.46 Billion BDT	45.53%
2009 Q1	243.34 Million BDT	-32.65%
2009 Q2	563.74 Million BDT	131.67%
2008 Q4	361.3 Million BDT	20.82%
2008 FY	1 Billion BDT	2.98%
2008 Q3	299.04 Million BDT	0.0%
2007 FY	979.16 Million BDT	-1.6%
2006 FY	995.03 Million BDT	19.15%
2005 FY	835.13 Million BDT	0.0%

Peer Operating Expenses Comparison of Beximco Pharmaceuticals Limited

Name	Operating Expenses	Operating Expenses Difference

Global Stocks Search

Beximco Pharmaceuticals Limited (BXP.L)

Operating Expenses Summary of Beximco Pharmaceuticals Limited

Annual Operating Expenses Chart of Beximco Pharmaceuticals Limited (2023 - 2005)

Historical Annual Operating Expenses of Beximco Pharmaceuticals Limited (2023 - 2005)

Peer Operating Expenses Comparison of Beximco Pharmaceuticals Limited